These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6165889)

  • 21. Vitamin K dependent in vitro production of prothrombin.
    Swanson JC; Suttie JW
    Biochemistry; 1982 Nov; 21(23):6011-8. PubMed ID: 6758841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prothrombin biosynthesis: characterization of processing events in rat liver microsomes.
    Swanson JC; Suttie JW
    Biochemistry; 1985 Jul; 24(15):3890-7. PubMed ID: 4052374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factor II antigen in liver disease and warfarin-induced vitamin K deficiency: correlation with coagulant activity using Echis venom.
    Corrigan JJ; Earnest DL
    Am J Hematol; 1980; 8(3):249-55. PubMed ID: 6774611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies in rats on in vitro inhibition and in vivo activity of vitamin-K-dependent carboxylation.
    Cocchetto DM; Bjornsson TD
    Haemostasis; 1986; 16(5):321-36. PubMed ID: 3781349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo effects of beta-lactam antibiotics and heterocyclic thiol compounds on vitamin K-dependent carboxylation activity and blood coagulation factors in vitamin K-deficient rats.
    Oka T; Touchi A; Harauchi T; Takano K; Yoshizaki T; Matsubara T
    Biochem Pharmacol; 1988 May; 37(10):2091-5. PubMed ID: 3377812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of warfarin on HepG2 cells suggest that prothrombin and factor X interact differently with the vitamin K-dependent carboxylase in the secretory pathway.
    Wallin R
    Thromb Res; 1991 May; 62(4):235-40. PubMed ID: 1866708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Process of carboxylation of glutamic acid residues in the gla domain of human des-gamma-carboxyprothrombin.
    Uehara S; Gotoh K; Handa H; Honjo K; Hirayama A
    Clin Chim Acta; 1999 Nov; 289(1-2):33-44. PubMed ID: 10556651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early processing of prothrombin and factor X by the vitamin K-dependent carboxylase.
    Wallin R; Martin LF
    J Biol Chem; 1988 Jul; 263(20):9994-10001. PubMed ID: 3290218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin K-dependent carboxylase. Solubilization and properties.
    Esmon CT; Suttie JW
    J Biol Chem; 1976 Oct; 251(20):6238-43. PubMed ID: 977568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism for potentiation of warfarin by phenylbutazone. Inhibition of vitamin K-dependent carboxylation and prothrombin synthesis by phenylbutazone in preparations from rat liver.
    Kelly LJ; Bell RG
    Biochem Pharmacol; 1981 Sep; 30(17):2443-9. PubMed ID: 21043243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of vitamin K-dependent carboxylation.
    Dubin A; Suen ET; Delaney R; Chiu A; Johnson BC
    J Biol Chem; 1980 Jan; 255(2):349-52. PubMed ID: 7356616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prothrombin antigen and coagulant activity in patients with liver disease.
    Corrigan JJ; Jeter M; Earnest DL
    JAMA; 1982 Oct; 248(14):1736-9. PubMed ID: 7120594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of vitamin E on warfarin-induced vitamin K deficiency.
    Corrigan JJ
    Ann N Y Acad Sci; 1982; 393():361-8. PubMed ID: 6959563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The biochemical basis of warfarin therapy.
    Suttie JW
    Adv Exp Med Biol; 1987; 214():3-16. PubMed ID: 3310547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abnormal prothrombin in the plasma of rats carrying hepatic tumors.
    Shah DV; Engelke JA; Suttie JW
    Blood; 1987 Mar; 69(3):850-4. PubMed ID: 3814818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolism and properties of a liver precursor to prothrombin.
    Suttie JW
    Vitam Horm; 1974; 32():463-81. PubMed ID: 4617405
    [No Abstract]   [Full Text] [Related]  

  • 37. The prevalence of vitamin K deficiency in chronic gastrointestinal disorders.
    Krasinski SD; Russell RM; Furie BC; Kruger SF; Jacques PF; Furie B
    Am J Clin Nutr; 1985 Mar; 41(3):639-43. PubMed ID: 3976564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on a family with combined functional deficiencies of vitamin K-dependent coagulation factors.
    Goldsmith GH; Pence RE; Ratnoff OD; Adelstein DJ; Furie B
    J Clin Invest; 1982 Jun; 69(6):1253-60. PubMed ID: 7085873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of congenital deficiency of multiple vitamin K-dependent coagulation factors and the phenotype of the warfarin embryopathy: clues to the mechanism of teratogenicity of coumarin derivatives.
    Pauli RM; Lian JB; Mosher DF; Suttie JW
    Am J Hum Genet; 1987 Oct; 41(4):566-83. PubMed ID: 3499071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased susceptibility to the anticoagulant effect of warfarin in mice bearing the Lewis lung carcinoma. Role of vitamin K deficiency.
    Pezzi L; Gerna M; Roncaglioni MC; Vermeer C; Donati MB
    Biochem Pharmacol; 1986 Oct; 35(19):3239-42. PubMed ID: 3768019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.